
Upgrades
For Sensei Biotherapeutics Inc (NASDAQ:SNSE), Oppenheimer upgraded the previous rating of Perform to Outperform. For the second quarter, Sensei Biotherapeutics had an EPS of $0.34, compared to year-ago quarter EPS of $0.32. The current stock performance of Sensei Biotherapeutics shows a 52-week-high of $6.17 and a 52-week-low of $1.45. Moreover, at the end of the last trading period, the closing price was at $1.55.